Clinical Trials Directory

Trials / Terminated

TerminatedNCT02552550

Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx

Analysis of Swallowing, Speech and Quality of Life of Patients With Stage T3-T4 Squamous Cell Carcinoma of the Oropharynx Before and After Multimodal Treatment With Curative Intent

Status
Terminated
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The curative treatment and organ preservation in advanced squamous cell carcinoma of the oropharynx is multimodal. It involves induction chemotherapy and depending on the response radio-chemotherapy or surgery. The combination of these methods has important functional consequences. The aim of this prospective pilot study is to describe swallowing, speech, but also patients' quality of life before and after therapeutic management (existing studies measuring these functions after treatment but not before).

Detailed description

This study will not change the patient's treatment. This will just be an evaluation, before any treatment, his ability to swallow, speak then, as in normal practice, after 3, 6 and 12 months after treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREAbility to swallow, speak and quality of lifeThis study will not change the patient's treatment. This will just be an evaluation, before any treatment, his ability to swallow, speak, then his quality of life, as in normal practice, after 3, 6 and 12 months after treatment.

Timeline

Start date
2013-07-25
Primary completion
2016-09-20
Completion
2016-09-20
First posted
2015-09-17
Last updated
2018-06-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02552550. Inclusion in this directory is not an endorsement.